Trademark Search  /  PHARMAGENIC ENRICHMENT

PHARMAGENIC ENRICHMENT

● Live · Registered

U.S. federal trademark · Serial No. 79389202 · Reg. No. 7772657

Mark
PHARMAGENIC ENRICHMENT
Status
Registered
Serial Number
79389202
Registration No.
7772657
Filing Date
January 17, 2024
Registration Date
April 29, 2025
Class(es)
Class 044

Owners

PolygenRx Pty Ltd
99 · AU
PolygenRx Pty Ltd
99 · AU
PolygenRx Pty Ltd
99 · AU

Goods & Services

Advisory services relating to pharmaceutical products, namely, providing information to patients in the field of administering medication; provision of pharmaceutical medical information; genetic testing for medical purposes; medical advisory services relating to medical problems; medical advisory services relating to medical services; alternative medical services; arranging of medical treatment, namely, providing medical treatment of chronic diseases in the nature of cardiometabolic, inflammatory, neurological, psychiatric, ophthalmological, musculoskeletal, respiratory, oncological, fibrotic, dermatological, hepatic and renal diseases; cardiology medical services; complementary medical services; conducting of medical examinations; general practice (GP) medical services; fitness testing, namely, medical testing for fitness evaluation; gastroenterology medical services; endocrinology medical services; dietetic counselling services, namely, dietic advisory services; medical consultancy and advisory services in relation to medical services; medical analysis of tissues for medical treatment for persons; health care consultancy services; health farm services in the nature of health spa services for health and wellness of the body and spirit offered at a health club facility; medical advice for individuals with disabilities; medical advisory services; medical analysis services relating to the treatment of patients; medical analysis services for diagnostic and treatment purposes provided by medical laboratories; medical analysis services for the diagnosis and treatment of persons; medical assistance; medical care services; medical clinic services; medical consulting services relating to offshore medical services; medical counselling; medical diagnostic services; medical examination of individuals; medical health assessment services; medical services in the field of oncology; medical screening; medical services; medical treatment services, namely, medical treatment of cardiometabolic, inflammatory, neurological, psychiatric, ophthalmological, musculoskeletal, respiratory, oncological, fibrotic, dermatological, hepatic and renal diseases; medical treatment using cultured cells; neurology medical services; oncology medical services; ophthalmology medical services; pediatric medical services; preparation of reports relating to medical matters in the nature of providing medical information to patients, medical professionals, medical providers, pharmacists, pathologists, pathology service providers, medical payers, including public and private health insurers, medical device distributors, pharmaceutical distributors, and biotechnology companies in the form of reports in the field of complex traits and disorders relating to cardiometabolic, inflammatory, neurological, psychiatric, ophthalmological, musculoskeletal, respiratory, oncological, fibrotic, dermatological, hepatic and renal diseases, including pharmaceutical-gene interactions, and predictions of the magnitude of response to treatments and interventions; providing medical information including online, about medical services; provision of medical assistance; provision of medical facilities, namely, leasing of equipped medical facilities that medical professionals can use on an as-needed basis; provision of medical information; provision of medical services; provision of medical treatment of cardiometabolic, inflammatory, neurological, psychiatric, ophthalmological, musculoskeletal, respiratory, oncological, fibrotic, dermatological, hepatic and renal diseases; services for the preparation of medical reports in the nature of providing medical information to patients, medical professionals, medical providers, pharmacists, pathologists, pathology service providers, medical payers, including public and private health insurers, medical device distributors, pharmaceutical distributors, and biotechnology companies in the form of reports in the field of cardiometabolic, inflammatory, neurological, psychiatric, ophthalmological, musculoskeletal, respiratory, oncological, fibrotic, dermatological, hepatic and renal diseases

Thinking of using a similar name?
Search 14 million+ trademarks free and see if your brand conflicts with "PHARMAGENIC ENRICHMENT" or anything like it, before you file.
Run a free trademark search →

Source: USPTO federal trademark records. Informational only, not legal advice. Status and details may lag the live USPTO database.